Lista de obras - Eric Bruckert - Dominio Público Uruguay

A Fully Automated Web-Based Program Improves Lifestyle Habits and HbA1c in Patients With Type 2 Diabetes and Abdominal Obesity: Randomized Trial of Patient E-Coaching Nutritional Support (The ANODE Study).

artículo científico publicado en 2017

Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients

artículo científico publicado en 2014

Cardiovascular risk and lifestyle habits of consumers of a phytosterol-enriched yogurt in a real-life setting

artículo científico publicado en 2014

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.

artículo científico publicado en 2015

Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: insights from a patient survey

artículo científico publicado en 2014

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

artículo científico publicado en 2015

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial

artículo científico publicado en 2014

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

artículo científico publicado en 2015

Familial hypercholesterolaemia: A global call to arms

artículo científico publicado en 2015

Giant xanthomas associated with severe mixed dyslipidemia and arteriosclerotic vascular disease: A case report

artículo científico publicado en 2015

Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia

artículo científico publicado en 2014

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

artículo científico publicado en 2014

Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia

artículo científico publicado en 2012

Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia.

artículo científico publicado en 2015

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

article

Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) - First Step Towards a Pro Measure in Lpld

artículo científico publicado en 2015

Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease)

artículo científico publicado en 2011

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

artículo científico publicado en 2003

Optimizing Cholesterol Treatment in Patients With Muscle Complaints.

artículo científico publicado en 2017

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) ⬇️

artículo científico publicado en 2018

Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case report

artículo científico publicado en 2015

Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement

artículo científico

Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion

artículo científico publicado en 2014

The Role of Nutraceuticals in Statin Intolerant Patients

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

artículo científico publicado en 2013

Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?

artículo científico publicado en 2018

[Assessing the cardiovascular risk in patients with systemic lupus erythematosus]

artículo científico publicado en 2014

Lista de obras de Eric Bruckert

A Fully Automated Web-Based Program Improves Lifestyle Habits and HbA1c in Patients With Type 2 Diabetes and Abdominal Obesity: Randomized Trial of Patient E-Coaching Nutritional Support (The ANODE Study).

Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients

Cardiovascular risk and lifestyle habits of consumers of a phytosterol-enriched yogurt in a real-life setting

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.

Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: insights from a patient survey

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Familial hypercholesterolaemia: A global call to arms

Giant xanthomas associated with severe mixed dyslipidemia and arteriosclerotic vascular disease: A case report

Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia

Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia.

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) - First Step Towards a Pro Measure in Lpld

Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease)

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Optimizing Cholesterol Treatment in Patients With Muscle Complaints.

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) ⬇️

Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case report

Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement

Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion

The Role of Nutraceuticals in Statin Intolerant Patients

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?

[Assessing the cardiovascular risk in patients with systemic lupus erythematosus]